Univest
Univest
  • Markets

CURIS LIFESCIENCES LTD (CURIS-SM): CURIS LIFESCIENCES Share Price rises 12.19% to Rs 169.8

  • September 7, 2026
  • Posted by: Harsh Piplani
  • Category: News
No Comments
CURIS LIFESCIENCES Share Price
CURIS LIFESCIENCES LTD (CURIS-SM) share price rose to Rs 169.8 today, up 12.19% from the previous close. Market cap was Rs 122.36 crore.

CURIS LIFESCIENCES Share Price is rising today, with the stock last traded at Rs 169.8, up 12.19% from the previous close of Rs 151.35. The company’s market capitalisation stands at Rs 122.36 crore, placing this move in a small-cap context within the Indian stock market. According to latest Univest data, the session has so far shown a clear price rise, but the numbers do not establish a company-specific catalyst. What the market can verify is that the share price moved from Rs 151.35 to Rs 169.8, and that the company is drawing attention as one of the notable stocks in news in Healthcare today. For investors tracking CURIS LIFESCIENCES Stock News, the key monitorables are the price action, the valuation profile, and whether the broader Pharmaceuticals & Drugs industry continues to support the move.

Table of Contents

Toggle
  • CURIS LIFESCIENCES Share Price Today: Price Action Analysis
  • CURIS LIFESCIENCES LTD (CURIS-SM) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching CURIS LIFESCIENCES
  • About CURIS LIFESCIENCES
  • Frequently Asked Questions
    • Why is CURIS LIFESCIENCES Share Price rising today?
    • What is CURIS LIFESCIENCES Share Price today?
    • What is the market cap of CURIS LIFESCIENCES?
    • How does CURIS LIFESCIENCES compare with sector valuations?
    • What do the EPS and book value mean for CURIS LIFESCIENCES?
    • Does CURIS LIFESCIENCES pay a dividend?
    • How strong are CURIS LIFESCIENCES return ratios?
    • Should investors track CURIS LIFESCIENCES Share Price on Univest?
  • Track CURIS LIFESCIENCES Share Price on Univest

CURIS LIFESCIENCES Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 169.8
Previous Close Rs 151.35
Today's Move Rs 18.45 (+12.19%)
Open Rs 151.35
High Rs 169.8
Low Rs 151.35
Turnover Rs 1.02 crore
Market Capitalisation Rs 122.36 crore
Market Cap Category Micro Cap

CURIS LIFESCIENCES LTD (CURIS-SM) rose to Rs 169.8 from the previous close of Rs 151.35, a move of Rs 18.45 or 12.19%. The stock opened at Rs 151.35, reached a high of Rs 169.8, recorded a low of Rs 151.35.

CURIS LIFESCIENCES Share Price Today reflects a strong intraday gain of Rs 18.45, or 12.19%, with the stock opening at Rs 151.35, touching a high of Rs 169.8 and holding near that level as of 07 September 2026 at 3:22:48 PM IST. The day’s low was also Rs 151.35, which means the stock has stayed above its opening level throughout the observed move. Turnover stood at Rs 1.02 crore, showing active trading interest in the share price rise. For readers following CURIS LIFESCIENCES Share Price Live and CURIS LIFESCIENCES Share Price Update, the event confirms a sharp upward move, while the latest Univest figures do not establish a company-specific trigger. In broader CURIS LIFESCIENCES Stock Performance terms, the move places it among the stocks rising today and among the top gainers today on a price basis.

CURIS LIFESCIENCES LTD (CURIS-SM) Fundamental Analysis

Metric Value
Market Capitalisation Rs 122.36 crore
P/E Ratio 17.69x
P/B Ratio 2.58x
ROE 55.25%
ROCE 34.25%
EPS Rs 8.56
Book Value Per Share Rs 58.58
Dividend Yield 0%

CURIS LIFESCIENCES LTD (CURIS-SM) fundamental metrics show P/E 17.69x, P/B 2.58x, ROE 55.25%, ROCE 34.25%. These figures provide context only and are not a buy or sell signal.

CURIS LIFESCIENCES LTD has a market capitalisation of Rs 122.36 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 17.69x, P/B at 2.58x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 55.25% and ROCE of 34.25%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 8.56, book value per share of Rs 58.58, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.83x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 17.69x
Benchmark Median P/E 32.83x
Benchmark Average P/E 48.79x
Benchmark P/E Range 3.2x to 659.73x
Company P/B Ratio 2.58x
Benchmark Median P/B 2.92x
Company ROE 55.25%
Benchmark Median ROE 11.78%
Company ROCE 34.25%
Benchmark Median ROCE 13.65%
Company Market Capitalisation Rs 122.36 crore
Benchmark Median Market Cap Rs 674.09 crore

CURIS LIFESCIENCES LTD (CURIS-SM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

CURIS LIFESCIENCES LTD (CURIS-SM) has a P/E ratio of 17.69x, which is below the benchmark median of 32.83x, a difference of -46.12%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

CURIS LIFESCIENCES LTD (CURIS-SM) has a ROE of 55.25%, which is above the benchmark median of 11.78%, a difference of +369.02%. CURIS LIFESCIENCES LTD (CURIS-SM) has a ROCE of 34.25%, which is above the benchmark median of 13.65%, a difference of +150.92%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,55,633.71 37.67 5.27 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 2,41,576.41 82.59 13.68 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,84,478.41 84.58 20.55 26.76 19.27
Cipla Ltd. CIPLA 1,11,888.39 33.19 3.18 11.83 16
Zydus Lifesciences Ltd. ZYDUSLIFE 1,11,820.18 24.78 4.15 19.69 21.39

CURIS LIFESCIENCES LTD (CURIS-SM) has a P/E ratio of 17.69x compared with the displayed peer median of 37.67x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 55.25% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 34.25% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. CURIS LIFESCIENCES LTD (CURIS-SM) has a market capitalisation of Rs 122.36 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching CURIS LIFESCIENCES

  • CURIS LIFESCIENCES Share Price rose 12.19% to Rs 169.8, making it a clear market mover in today’s trade.
  • The stock’s P/E of 17.69 is below the same-industry median and average, which keeps CURIS LIFESCIENCES Fundamental Analysis in focus.
  • ROE of 55.25 and ROCE of 34.25 indicate strong capital efficiency relative to the sector benchmark.
  • The market cap of Rs 122.36 crore places the company in a smaller size bucket, where price action can stand out quickly.
  • Healthcare sector peers trade at much larger valuations, which gives CURIS LIFESCIENCES Share Price a distinct comparison point in stock analysis.

About CURIS LIFESCIENCES

CURIS LIFESCIENCES LTD operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The latest Univest figures place it within a small-cap profile, with a market capitalisation of Rs 122.36 crore and turnover of Rs 1.02 crore on the day of the move. The company description in market data identifies it within pharmaceutical and drug-related business activity, which is typically assessed through earnings quality, return ratios, valuation multiples and sector placement rather than size alone.

For investors following CURIS LIFESCIENCES Latest News, the main company-level context is that the share price rise is backed by a low-teen P/E, a P/B below the industry median, and return ratios that stand well above the same-industry benchmark. That makes CURIS LIFESCIENCES Company News relevant not just as a price move, but as a case study in how a smaller healthcare stock can attract attention when market participants compare fundamentals with sector peers.

Frequently Asked Questions

Why is CURIS LIFESCIENCES Share Price rising today?

Ans. CURIS LIFESCIENCES Share Price is up 12.19% today to Rs 169.8. The latest Univest figures confirm the move, but they do not establish a company-specific catalyst, so investors should read it as verified price action.

What is CURIS LIFESCIENCES Share Price today?

Ans. CURIS LIFESCIENCES Share Price Today is Rs 169.8, compared with the previous close of Rs 151.35. That places the stock Rs 18.45 higher in the current market update.

What is the market cap of CURIS LIFESCIENCES?

Ans. CURIS LIFESCIENCES has a market capitalisation of Rs 122.36 crore. That makes it a smaller company in the Healthcare sector, so even moderate trading interest can visibly affect CURIS LIFESCIENCES Share Price.

How does CURIS LIFESCIENCES compare with sector valuations?

Ans. CURIS LIFESCIENCES Share Price trades with a P/E of 17.69 and P/B of 2.58, both below the same-industry median. Its ROE and ROCE are above the benchmark, which adds fundamental context.

What do the EPS and book value mean for CURIS LIFESCIENCES?

Ans. EPS is 8.56 and book value is Rs 58.58 per share. EPS reflects earnings attributable to each share, while book value shows accounting net worth per share behind CURIS LIFESCIENCES Share Price.

Does CURIS LIFESCIENCES pay a dividend?

Ans. The dividend yield is 0, so the current CURIS LIFESCIENCES Share Price case is not supported by an income yield. Investors are instead looking at earnings, book value and return ratios for context.

How strong are CURIS LIFESCIENCES return ratios?

Ans. CURIS LIFESCIENCES reports ROE of 55.25 and ROCE of 34.25. Both are well above the same-industry benchmark, which is one reason CURIS LIFESCIENCES Share Price is drawing attention today.

Should investors track CURIS LIFESCIENCES Share Price on Univest?

Ans. Yes, investors can track CURIS LIFESCIENCES Share Price on Univest for live price updates, valuation ratios, company financials, sector comparison and market insights. That helps keep the stock analysis organised in one place.

Track CURIS LIFESCIENCES Share Price on Univest

Use CURIS LIFESCIENCES LTD (CURIS-SM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Investors can track CURIS LIFESCIENCES Share Price on Univest for live updates, market cap, valuation ratios, company financials, sector comparison and stock performance. Univest also helps readers monitor CURIS LIFESCIENCES Share Price Today alongside broader market insights, including peer context and the latest stock updates.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).



Author: Harsh Piplani
I am Harsh Piplani, an Assistant Content Manager with over 5 years of experience in crafting impactful, result-driven content. I hold a B.Com (Hons) degree and have worked across diverse industries, including education, fintech, healthcare, jewellery, and more. I specialise in content strategy, SEO, and optimisation, ensuring that every piece I create is not just well-written but also well-ranked. I believe content should do more than fill space so as to drive traffic, build authority, and support business growth. I enjoy turning complex ideas into clear, engaging narratives, and, as I like to say, I know how to spin words like a web to influence, structured, strategic, and impossible to ignore. For me, great content sits at the intersection of creativity and performance.

Leave a Reply Cancel reply